中信证券研报表示，2025年6月美国新增非农就业人数超预期，失业率低于预期。不过，本份非农报告 实则显示美国就业市场继续走弱。依旧认为美国就业市场"缓冲垫"有限，就业市场继续走弱失业率或将 加快上行。延续此前观点，预计美联储将在9月的议息会议上再度降息。 ③中金公司：非农韧性不支持美联储提前降息 美联储的降息路径现重大变数，多家券商早间发布最新观点>> 7月3日，美国劳工统计局统计数据显示，6月非农就业岗位增加14.7万个，预期为11万个。失业率降至 4.1%，预期为4.3%。在非农数据公布后，芝加哥商品交易所的美联储观察工具显示，7月降息可能性降 至个位数。美联储的降息路径现重大变数，多家券商早间发布最新观点： ①华泰证券：6月非农再超预期，7月降息概率回落 华泰证券表示，6月新增非农数据再超预期，美联储7月降息概率进一步下降，但考虑到关税、移民放缓 对三季度新增就业的拖累，维持联储9月-12月两次预防式降息的判断。6月新增非农超预期、失业率超 预期下行或受到多个因素干扰，未改变就业市场放缓的趋势：6月天气偏热叠加罢工拖累消退，对新增 非农提振约在3-4万人左右；5-6月美国劳动力规模下降75.5万人、劳动 ...

Core Insights - The domestic ETF market experienced significant growth in the first half of 2025, with total ETF assets surpassing 4 trillion yuan, increasing from 3.73 trillion yuan at the beginning of the year to 4.31 trillion yuan by mid-year [1][2] - Several new and existing ETFs gained substantial inflows, with notable contributions from major fund companies such as Huaxia Fund, E Fund, and Fuguo Fund, which added 928.32 billion yuan, 648.66 billion yuan, and 513.71 billion yuan respectively [1][2] - The focus of ETF fund managers is shifting from brand promotion to achieving scale, driven by new policies and regulatory guidance [7][8] ETF Market Growth - The total scale of domestic ETFs reached over 4 trillion yuan for the first time, with an increase of over 580 billion yuan in the first half of 2025 [1] - Eight public fund institutions added between 20 billion yuan and 50 billion yuan in ETF management scale, while ten institutions added between 5 billion yuan and 20 billion yuan [2] - The market saw multiple standout products across various sectors, indicating a broad-based growth in ETF inflows [2] Performance of Existing Products - Several existing ETFs revitalized their performance, with the Huaxia Gold ETF and Fuguo China-Hong Kong Internet ETF seeing net inflows of 311.47 billion yuan and 257.27 billion yuan respectively [3] - Other ETFs, such as the Industrial Bank China-Hong Kong Technology ETF and Huaxia China-Robotics ETF, also experienced significant scale increases, each exceeding 100 billion yuan [3] New Product Launches - The first batch of benchmark market-making credit bond ETFs gained attention, with several funds exceeding 20 billion yuan in scale by mid-year [4] - Existing products like the Hai Futong China Short-term Bond ETF also saw substantial growth, with nearly 20 billion yuan added in the first half of the year [4] Strategic Focus of Fund Managers - Fund managers are advised to focus on innovative potential products and maintain a robust marketing strategy to capture market share [8] - The competitive landscape is expected to continue, with leading products maintaining an advantage due to their established resources and market presence [7][8]

Core Viewpoint - The price of soda ash is experiencing a significant decline, with the average market price in North China dropping by 8.0% in Q2 2025, reaching 1483 RMB/ton, and a cumulative decline of 50.2% since the beginning of 2024 [1] Price Trends - Since the beginning of 2024, soda ash prices have entered a downward trend, with the average market price in North China at 1370 RMB/ton by the end of June 2025, reflecting a 50.2% decrease from early 2024 [1] - In Q2 2025, the average price in North China was 1483 RMB/ton, down 8.0% from Q1 [1] - Coal prices have also declined, with the average price of 5500 kcal thermal coal at Qinhuangdao Port being 632 RMB/ton in Q2, a 12.4% decrease from Q1 [1] Profitability of Production Processes - The decline in soda ash prices has led to some production processes entering a state of reduced profitability. The dynamic gross profit margins for the main production methods as of June 2025 are approximately 415 RMB/ton for natural soda ash, -54 RMB/ton for the ammonia soda process, and -152 RMB/ton for the soda ash process [2] - In Q2 2025, the average gross profit margins for these processes were 516 RMB/ton, 15 RMB/ton, and -66 RMB/ton, respectively, indicating a significant squeeze on profitability [2] Industry Capacity and Expansion - The domestic effective capacity for soda ash in 2024 is projected to be around 39.7 million tons, an increase of 1.8 million tons or 4.7% year-on-year [3] - New capacity additions are still expected in 2025, including the completion of a 600,000-ton ammonia soda expansion project by Jiangsu Debang and the relocation and upgrade of a 1.1 million-ton ammonia soda facility by Lianyungang Soda Industry [3] Structural Changes in the Industry - By the end of 2024, the capacity shares for natural soda ash, ammonia soda, and soda ash processes are expected to be 15%, 49%, and 36%, respectively, with natural soda ash's share significantly increasing from 4.6% at the end of 2022 [4] - The increase in natural soda ash and ammonia soda capacity, combined with declining soda ash prices, may lead to the marginalization of some smaller ammonia soda capacities [4] - Recent policy measures emphasize the regulation of low-price competition, which may accelerate the exit of outdated capacities and promote structural adjustments within the soda ash industry [4]

Group 1 - The heavy truck market in June saw a significant year-on-year increase of 28.9%, with total sales reaching approximately 92,000 units, marking the third consecutive month of year-on-year growth [2][4] - The first half of the year recorded total heavy truck sales of 533,000 units, reflecting a year-on-year growth of 5.8% [2][4] - The domestic terminal demand exceeded expectations, with a year-on-year increase of over 36%, driven by the implementation of scrapping and replacement policies [3] Group 2 - Traditional diesel and new energy vehicles contributed significantly to the sales increase, with diesel heavy trucks growing approximately 52% year-on-year [3] - New energy heavy trucks saw sales surpassing 15,000 units in June, achieving a penetration rate of over 24%, which represents a year-on-year growth of 120% [3] - The export market remained robust, with a nearly 10% year-on-year increase in June, despite a 95% decline in exports to Russia [3][4] Group 3 - The heavy truck sector is expected to maintain a positive trend in the third quarter, with anticipated average monthly sales exceeding 80,000 units and a year-on-year growth rate of over 30% [4] - The market sentiment regarding exports has improved, with non-Russian exports growing over 30% year-on-year, indicating strong demand from regions like the Middle East and South America [4] - The continuous inventory reduction in domestic channels over the past three months is expected to enhance market confidence and lead to stronger wholesale sales growth [4]

Core Viewpoint - The insurance industry is recommended for investment, with current A-share insurance companies at low historical levels and limited downside risk. The investment side is expected to improve gradually due to stabilizing stock markets and recovering interest rates, while the liability side benefits from recovering sales of savings insurance and increased demand for high-end medical insurance [1][3]. Group 1: Investment Outlook - The insurance sector is expected to see a gradual improvement in investment returns due to stabilizing stock markets and recovering interest rates [1]. - The sales of savings insurance are rebounding, and the demand for high-end medical insurance is being catalyzed by medical reforms, which will enhance the new business value margin (NBVM) and support steady growth in new business value (NBV) [1][3]. Group 2: Regulatory Changes - The maximum preset interest rate for life insurance products may be lowered by 50 basis points to 2.0% by the end of August, following regulatory guidelines that require adjustments when preset rates exceed certain thresholds [2]. - The insurance industry is expected to see a reduction in the cost of new policy funds due to the adjustment of preset interest rates, which will alleviate risks associated with interest rate spreads [3]. Group 3: Market Dynamics - The insurance sector is entering a phase of improved premium growth as it approaches a seasonal period of product suspension, with ongoing adjustments in product structure expected to optimize costs further [3]. - The combination of regulatory changes and market dynamics is likely to lead to a significant improvement in the industry's fundamentals, with a continued positive trend anticipated [1][3].

Group 1 - The core viewpoint is that deep-sea technology has been recognized as a strategic emerging industry in China's 2025 government work report, alongside commercial aerospace and low-altitude economy, highlighting its potential for economic growth and resource security [1][3] - The deep-sea area covers 65% of the ocean and 49% of the Earth's surface, containing abundant energy and resources, making it crucial for China's economic strategy and international standing [2][3] - The deep-sea technology sector is expected to experience rapid development, with a market potential in the trillion-level range, driven by government policies and financing opportunities [3] Group 2 - The construction of underwater defense systems is accelerating, with military-civilian integration expected to drive growth in the deep-sea industry, enhancing the application and commercialization of deep-sea equipment [4] - The upstream sector, including sonar and titanium alloy production, is anticipated to see early growth, while midstream and downstream applications are expanding into various deep-sea scenarios [5] - Key companies in the upstream sector include China Marine Defense, West Materials, and Xiangdian Co., while midstream and downstream players include China Shipbuilding, CNOOC, and China Petroleum [5]

梦网云科技集团股份有限公司（以下简称"公司"）拟发行股份及支付现金购买杭 州碧橙数字技术股份有限公司全部股份并募集配套资金（以下简称"本次交易"）。方 正证券承销保荐有限责任公司（以下简称"本独立财务顾问"）作为本次交易的独立财 务顾问，对公司本次交易前 12 个月内购买、出售资产的情况进行了核查，具体内容 如下： 根据《上市公司重大资产重组管理办法》第十四条第（四）项的规定： "上市公司 在十二个月内连续对同一或者相关资产进行购买、出售的，以其累计数分别计算相应 数额。已按照本办法的规定编制并披露重大资产重组报告书的资产交易行为，无须纳 入累计计算的范围。中国证监会对本办法第十三条第一款规定的重大资产重组的累计 期限和范围另有规定的，从其规定。交易标的资产属于同一交易方所有或者控制，或 者属于相同或者相近的业务范围，或者中国证监会认定的其他情形下，可以认定为同 一或者相关资产。" 方正证券承销保荐有限责任公司 经核查，本独立财务顾问认为：在本次交易前 12 个月内，公司未发生与本次交 易相关的购买、出售资产的交易行为，不存在需要纳入累计计算范围的情形。 关于本次交易前 12 个月内购买、出售资产情况的核查意 ...

Group 1 - The company, DreamNet Cloud Technology Group Co., Ltd., plans to issue shares and pay cash to acquire all shares of Hangzhou Bicheng Digital Technology Co., Ltd., along with raising supporting funds for this transaction [1][2] - The independent financial advisor, Founder Securities, conducted a review and found no direct or indirect paid hiring of third-party institutions or individuals in this transaction [1][2] - The company has legally and compliantly hired necessary securities service institutions for this transaction, including Founder Securities as the independent financial advisor, Beijing Guofeng Law Firm as the legal advisor, Zhongxi CPA as the auditing firm, Shanghai Zhonghua Asset Appraisal Co., Ltd. for valuation, and Hong Kong Yu Peiheng Law Firm for special legal opinions regarding the Hong Kong subsidiary [1][2] Group 2 - The independent financial advisor confirmed that the hiring of the mentioned securities service institutions is in accordance with the regulations outlined in the CSRC's notice on strengthening risk prevention in investment banking [2]

Core Viewpoint - From June 26, 2025, certain funds managed by Nuon Fund Management Co., Ltd. will be available for purchase and redemption through Founder Securities Co., Ltd. as a sales institution [1][2]. Group 1: Fund Sales and Services - Investors can handle subscription, redemption, and related inquiries for the specified funds through Founder Securities starting June 26, 2025 [1]. - The company will also enable regular investment and conversion services for these funds at Founder Securities, along with participation in fee discount activities [1][2]. Group 2: Fund Investment Options - Starting June 26, 2025, investors can perform regular investment operations for the specified funds through Founder Securities, with the subscription fee rate being the same as the normal subscription fee rate [1][3]. - Fund conversion services will also be available for the specified funds and other convertible funds managed by the company, with rules and fees detailed in the latest prospectus [2][3]. Group 3: Fee Rate Discounts - Investors will enjoy subscription fee discounts for both subscription and regular investment operations through Founder Securities, subject to the institution's regulations [3]. - The specific standards for fund fees can be found in the latest prospectus and related legal documents published by the company [3]. Group 4: Minimum Investment Requirements - The minimum subscription amount for money market funds through Founder Securities is set at 0.01 yuan (including subscription fees), while for non-money market funds, it is set at 1 yuan (including subscription fees) [4]. - Different share classes of the same fund cannot be converted into each other [5].

Group 1 - The core viewpoint is that the innovative drug market is still optimistic, with ongoing revaluation of innovative drug assets and a focus on the second-generation IO and ASCO data releases, as well as the valuation reshaping of pharma companies [1][2] - The pharmaceutical index increased by 1.40% during the week of June 9-14, 2025, outperforming the CSI 300 index, which decreased by 0.25%, resulting in a relative outperformance of 1.66% [1] - The current PE (TTM) for the pharmaceutical and biological industry is 28.41 times, compared to 12.04 times for the CSI 300 index, indicating a valuation premium of 135.95% for the pharmaceutical sector, which remains at a historical low [1] Group 2 - The current innovative drug market reflects a recognition of the business model of innovative drugs, driven by leading companies like BeiGene, Innovent Biologics, and Hengrui Medicine, which are expected to turn profitable through business development or globalization in 2024 or Q1 2025 [2] - The collective rise of leading innovative drug stocks indicates a systematic revaluation of their long-term R&D investment value, with the overall valuation center of the innovative drug sector moving upward due to long-term expectations of industry upgrades [2] - The current innovative drug market is characterized by data asset pricing rather than business development pricing, where high-quality and globally leading R&D asset data will attract reasonable market valuations regardless of short-term fluctuations in business development [2]